Advertisement

Urolithiasis

, Volume 47, Issue 1, pp 115–123 | Cite as

Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms

  • Giovanni GambaroEmail author
  • G. Zaza
  • F. Citterio
  • A. Naticchia
  • P. M. Ferraro
Invited Review
  • 88 Downloads

Abstract

Deciding whether to accept a donor with nephrolithiasis is a multifaceted task because of the challenge of finding enough suitable donors while at the same time ensuring the safety of both donors and recipients. Until not long ago, donors with a history of renal stones or with stones emerging during screening on imaging were not considered ideal, but recent guidelines have adopted less stringent criteria for potential donors at risk of stones. This review goes through the problems that need to be approached to arrive at a wise clinical decision, balancing the safety of donors and recipients with the need to expand the organ pool. The risk of declining renal function and worsening stone formation is examined. Documents (consensus statements, guidelines, etc.) on this issue released by the most important medical societies and organizations are discussed and compared. Specific problems of living kidney donation associated with certain systemic (chronic hypercalcemia due to CYP24A1 gene mutations, primary hyperoxaluria, APRT deficiency) and renal (medullary sponge kidney, cystinuria, distal renal tubular acidosis, Dent’s disease, Bartter syndrome, familial hypomagnesemia with hypercalciuria and nephrocalcinosis) Mendelian disorders that cause nephrolithiasis are also addressed.

Keywords

Guidelines Kidney transplantation Living donation Mendelian disease Renal stone 

Notes

Acknowledgements

This review was supported by an in-house grant from the Università Cattolica del Sacro Cuore.

Compliance with ethical standards

Conflict of interest

Authors have no conflict of interest.

References

  1. 1.
    Croppi E, Ferraro PM, Taddei L, Gambaro G, GEA Firenze Study Group (2012) Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res 40(5):517–522Google Scholar
  2. 2.
    Lorenz EC, Lieske JC, Vrtiska TJ, Krambeck AE, Li X, Bergstralh EJ, Melton LJ 3rd, Rule AD (2011) Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 26(8):2695–2700Google Scholar
  3. 3.
    Olsburgh J, Thomas K, Wong K, Bultitude M, Glass J, Rottenberg G, Silas L, Hilton R, Koffman G (2013) Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy. BJU Int 111(5):784–792Google Scholar
  4. 4.
    Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX, Chronic Kidney Disease Prognosis Consortium (2016) Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 374(5):411–421Google Scholar
  5. 5.
    Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M, Alberta Kidney Disease Network (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287Google Scholar
  6. 6.
    El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415Google Scholar
  7. 7.
    Gambaro G, Croppi E, Bushinsky D, Jaeger P, Cupisti A, Ticinesi A, Mazzaferro S, D’Addessi A, Ferraro PM (2017) The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review. J Urol 198(2):268–273Google Scholar
  8. 8.
    Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64(6):2204–2213Google Scholar
  9. 9.
    Bush NC, Xu L, Brown BJ, Holzer MS, Gingrich A, Schuler B, Tong L, Baker LA (2010) Hospitalizations for pediatric stone disease in United States, 2002–2007. J Urol 183(3):1151–1156Google Scholar
  10. 10.
    Assimos DG, Leslie SW, Ng C, Streem SB, Hart LJ (2002) The impact of cystinuria on renal function. J Urol 168(1):27–30Google Scholar
  11. 11.
    Lee YH, Huang WC, Chang LS, Chen MT, Yang YF, Huang JK (1994) The long-term stone recurrence rate and renal function change in unilateral nephrectomy urolithiasis patients. J Urol 152:1386–1388Google Scholar
  12. 12.
    Ferraro PM, Curhan GC, D’Addessi A, Gambaro G (2017) Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol 30(2):227–233Google Scholar
  13. 13.
    Kim IK, Tan JC, Lapasia J, Elihu A, Busque S, Melcher ML (2012) Incidental kidney stones: a single center experience with kidney donor selection. Clin Transpl 26(4):558–563Google Scholar
  14. 14.
    Rizkala E, Coleman S, Tran C, Isac W, Flechner SM, Goldfarb D, Monga M (2013) Stone disease in living-related renal donors: long-term outcomes for transplant donors and recipients. J Endourol 27(12):1520–1524Google Scholar
  15. 15.
    Serur D, Charlton M, Juluru K, Salama G, Locastro E, Bretzlaff G, Hartono C (2017) Long-term follow-up of kidney donors with asymptomatic renal stones. Nephrology (Carlton) 22(8):649–651Google Scholar
  16. 16.
    Skrunes R, Svarstad E, Reisæter AV, Vikse BE (2014) Familial clustering of ESRD in the Norwegian population. Clin J Am Soc Nephrol 9(10):1692–1700Google Scholar
  17. 17.
    Maggiore U, Budde K, Heemann U, Hilbrands L, Oberbauer R, Oniscu GC, Pascual J, Schwartz Sorensen S, Viklicky O, Abramowicz D, ERA-EDTA DESCARTES Working Group (2017) Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES Working Group. Nephrol Dial Transpl 32(2):216–223Google Scholar
  18. 18.
    Delmonico F, Council of the Transplantation Society (2005) A report of the Amsterdam Forum on the care of the live kidney donor: data and medical guidelines. Transplantation 79(6 Suppl):S53–S66Google Scholar
  19. 19.
    Kasiske BL, Ravenscraft M, Ramos EL, Gaston RS, Bia MJ, Danovitch GM (1996) The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 7(11):2288–2313Google Scholar
  20. 20.
    European Renal Best Practice Transplantation Guideline Development Group (2013) ERBP Guideline on the management and evaluation of the kidney donor and recipient. Nephrol Dial Transpl 28(Suppl 2):ii1–i71Google Scholar
  21. 21.
    Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX (2017) KDIGO Clinical Practice Guideline on the evaluation and care of living kidney donors. Transplantation 101(8S Suppl 1):S1–S109Google Scholar
  22. 22.
    British Transplantation Society (2018) Guidelines for living donor kidney transplantation, https://bts.org.uk/wp-content/uploads/2018/07/FINAL_LDKT-guidelines_June-2018.pdf. Accessed 21 Aug 2018
  23. 23.
    Gambaro G, Reis-Santos JM, Rao N (2004) Nephrolithiasis: why doesn’t our “learning”. progress? Eur Urol 45(5):547–556Google Scholar
  24. 24.
    Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, Fuster D, Goldfarb DS, Heilberg IP, Hess B, Lieske J, Marangella M, Milliner D, Preminger GM, Reis Santos JM, Sakhaee K, Sarica K, Siener R, Strazzullo P, Williams JC; Consensus Conference Group (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734Google Scholar
  25. 25.
    Rule AD, Lieske JC, Li X, Melton LJ 3rd, Krambeck AE, Bergstralh EJ (2014) The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol 25(12):2878–2886Google Scholar
  26. 26.
    Health Resources and Services Administration, U.S. Department of Health & Human Services (2018) https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf. Accessed 21 Aug 2018
  27. 27.
    Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Akhtar F, Zafar MN, Hussain M, Ahmed E, Kazi JI, Hasan AS, Khalid R, Aziz S, Sultan S (2002) Living-related pediatric renal transplants: a single-center experience from a developing country. Pediatr Transpl 6(2):101–110Google Scholar
  28. 28.
    Riese RJ, Sakhaee K (1992) Uric acid nephrolithiasis: pathogenesis and treatment. J Urol 148(3):765–771Google Scholar
  29. 29.
    Moe OW, Xu LHR (2018) Hyperuricosuric calcium urolithiasis. J Nephrol 31(2):189–196Google Scholar
  30. 30.
    O’Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA (2016) Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos Int 27(10):3121–3125Google Scholar
  31. 31.
    Ferraro PM, Minucci A, Primiano A, De Paolis E, Gervasoni J, Persichilli S, Naticchia A, Capoluongo E, Gambaro G (2017) A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass. Urolithiasis 45(3):291–294Google Scholar
  32. 32.
    Dindo M, Conter C, Oppici E, Ceccarelli V, Marinucci L, Cellini B (2018) Molecular basis of primary hyperoxaluria: clues to innovative treatments. Urolithiasis.  https://doi.org/10.1007/s00240-018-1089-z Google Scholar
  33. 33.
    Hoppe B, Beck BB, Milliner DS (2009) The primary hyperoxalurias. Kidney Int 75:1264–1271Google Scholar
  34. 34.
    Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N (1995) Epidemiology of primary hyperoxaluria type 1. Société de Néphrologie and the Société de Néphrologie Pédiatrique. Nephrol Dial Transplant 10(Suppl 8):3–7Google Scholar
  35. 35.
    Nanmoku K, Kurosawa A, Shinzato T, Shimizu T, Kimura T, Yagisawa T (2017) Febuxostat for the prevention of recurrent 2,8-dihydroxyadenine nephropathy due to adenine phosphoribosyltransferase deficiency following kidney transplantation. Intern Med 56(11):1387–1391Google Scholar
  36. 36.
    Marra G, Taroni F, Berrettini A, Montanari E, Manzoni G, Montini G (2018) Pediatric nephrolithiasis: a systematic approach from diagnosis to treatment. J Nephrol.  https://doi.org/10.1007/s40620-018-0487-1 Google Scholar
  37. 37.
    Mohebbi N, Ferraro PM, Gambaro G, Unwin R (2017) Tubular and genetic disorders associated with kidney stones. Urolithiasis 45(1):127–137Google Scholar
  38. 38.
    Fabris A, Lupo A, Bernich P, Abaterusso C, Marchionna N, Nouvenne A, Gambaro G (2010) Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol 5(9):1663–1668Google Scholar
  39. 39.
    Gambaro G, Goldfarb DS, Baccaro R, Hirsch J, Topilow N, D’Alonzo S, Gambassi G, Ferraro PM (2018) Chronic pain in medullary sponge kidney: a rare and never described clinical presentation. J Nephrol 31(4):537–542Google Scholar
  40. 40.
    Fabris A, Anglani F, Lupo A, Gambaro G (2013) Medullary sponge kidney: state of the art. Nephrol Dial Transpl 28(5):1111–1119Google Scholar
  41. 41.
    Fabris A, Lupo A, Ferraro PM, Anglani F, Pei Y, Danza FM, Gambaro G (2013) Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int 83(2):272–277Google Scholar
  42. 42.
    Ria P, Fabris A, Dalla Gassa A, Zaza G, Lupo A, Gambaro G (2017) New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. Urolithiasis 45(4):359–362Google Scholar
  43. 43.
    Gambaro G, Danza FM, Fabris A (2013) Medullary sponge kidney. Curr Opin Nephrol Hypertens 22(4):421–426Google Scholar
  44. 44.
    Cheungpasitporn W, Thongprayoon C, Brabec BA, Kittanamongkolchai W, Erickson SB (2016) Outcomes of living kidney donors with medullary sponge kidney. Clin Kidney J 9(6):866–870Google Scholar
  45. 45.
    Gambaro G et al (2012) Re: McPhail Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. Urology 80:1395–1396 (Urology 2012 79(6):277–281) Google Scholar
  46. 46.
    Ferraro PM, D’Addessi A, Gambaro G (2013) When to suspect a genetic disorder in a patient with renal stones, and why. Nephrol Dial Transpl 28(4):811–820Google Scholar
  47. 47.
    Reinstatler L, Stern K, Batter H, Scotland KB, Ardekani GS, Rivera M, Chew BH, Eisner B, Krambeck AE, Monga M, Pais VM Jr (2018) Conversion from cystine to non-cystine stones: incidence and associated factors. J Urol.  https://doi.org/10.1016/j.juro.2018.07.047 Google Scholar
  48. 48.
    Tuso P, Barnett M, Yasunaga C, Nortman D (1993) Cystinuria and renal transplantation. Nephron 63(4):478Google Scholar
  49. 49.
    Rhodes HL, Yarram-Smith L, Rice SJ, Tabaksert A, Edwards N, Hartley A, Woodward MN, Smithson SL, Tomson C, Welsh GI, Williams M, Thwaites DT, Sayer JA, Coward RJ (2015) Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol 10(7):1235–1245Google Scholar
  50. 50.
    Mohebbi N, Wagner CA (2018) Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol 31(4):511–522Google Scholar
  51. 51.
    Faller N, Dhayat NA, Fuster DG (2019) Nephrolithiasis secondary to inherited defects in the thick ascending loop of Henle and connecting tubules. Urolithiasis.  https://doi.org/10.1007/s00240-018-1097-z (current issue)Google Scholar
  52. 52.
    Zhang J, Fuster DG, Cameron MA, Quinones H, Griffith C, Xie XS, Moe OW (2014) Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit. Am J Physiol Renal Physiol 307(9):F1063–F1071Google Scholar
  53. 53.
    Dhayat NA, Schaller A, Albano G, Poindexter J, Griffith C, Pasch A, Gallati S, Vogt B, Moe OW, Fuster DG (2016) The vacuolar H+-ATPase B1 subunit polymorphism p.E161K associates with impaired urinary acidification in recurrent stone formers. J Am Soc Nephrol 27(5):1544–1554Google Scholar
  54. 54.
    Sromicki JJ, Hess B (2017) Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment. Urolithiasis 45(3):263–269Google Scholar
  55. 55.
    Carvalho M, Erbano BO, Kuwaki EY, Pontes HP, Liu JWTW, Boros LH, Asinelli MO, Baena CP (2017) Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: systematic review and meta-analysis. Urolithiasis 45(5):449–455Google Scholar
  56. 56.
    Wrong OM, Norden AG, Feest TG (1994) Dent’s disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87:473–493Google Scholar
  57. 57.
    Gambaro G, Naticchia A, Ferraro PM, Romagnoli J, Salerno MP, Citterio F. Living kidney donation in a type 1 Dent’s disease patient from his mother (submitted)Google Scholar
  58. 58.
    Chaudhuri A, Salvatierra O Jr, Alexander SR, Sarwal MM (2006) Option of pre-emptive nephrectomy and renal transplantation for Bartter’s syndrome. Pediatr Transpl 10(2):266–270Google Scholar
  59. 59.
    Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, Araque A, Ortiz A, Rodicio JL (1995) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 47:1419–1425Google Scholar
  60. 60.
    Arteaga ME, Hunziker W, Teo AS, Hillmer AM, Mutchinick OM (2015) Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry. Ren Fail 37(1):180–183Google Scholar
  61. 61.
    Almeida JR, Machado Gde A, dos Santos MM, Lopes Pde F, de Matos JP, Neves AC, Lugon JR (2014) Five years results after intrafamilial kidney post-transplant in a case of familial hypomagnesemia due to a claudin-19 mutation. J Bras Nefrol 36(3):401–405Google Scholar
  62. 62.
    Giessing M, Fuller F, Tuellmann M, Liefeld L, Slowinski T, Budde K, Loening SA (2008) Attitude to nephrolithiasis in the potential living kidney donor: a survey of the German kidney transplant centers and review of the literature. Clin Transpl 22(4):476–483Google Scholar
  63. 63.
    Ferraro PM, Ticinesi A, Meschi T, Rodgers A, Di Maio F, Fulignati P, Borghi L, Gambaro G (2018) Short-term changes in urinary relative supersaturation predict recurrence of kidney stones: a tool to guide preventive measures in urolithiasis. J Urol.  https://doi.org/10.1016/j.juro.2018.06.029 Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.UOC Nefrologia, Fondazione Policlinico Universitario A. Gemelli IRCCSRomeItaly
  2. 2.Renal Unit, Department of MedicineUniversity Hospital of VeronaVeronaItaly
  3. 3.UOSA Trapianto di rene, Fondazione Policlinico Universitario A. Gemelli IRCCSRomeItaly
  4. 4.Università Cattolica del Sacro CuoreRomeItaly

Personalised recommendations